urocanic acid and chitosan

urocanic acid has been researched along with chitosan in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's5 (45.45)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Cho, CS; Choi, YJ; Ihm, JE; Kim, TH; Nah, JW1
Anderson, HK; Chang, SH; Cho, CS; Cho, MH; Colburn, NH; Hwang, SK; Jin, H; Kim, HW; Kim, TH; Lee, HW; Lee, KH; Yang, HS1
Chang, SH; Cho, CS; Cho, MH; Chung, YS; Hwang, SK; Jin, H; Kim, DY; Kim, HW; Kim, TH; Kwon, JT; Lee, ES; Lee, KH; Minai-Tehrani, A; Noh, MS; Park, SJ; Shin, JY; Woo, M; Xu, CX; Yoon, BI; Youn, HJ1
Li, YP; Lu, Y; Tao, L; Wang, W; Wang, Y; Yao, J; Zhou, JP1
Li, YP; Wang, W; Yao, J; Zhou, JP1
Han, L; Tang, C; Yin, C1
Ma, P; Merlin, D; Viennois, E; Xiao, B1
Cheng, TK; Chiang, TM; Hsueh, YS; Kuo, TF; Lin, FH; Mestak, O; Shieh, MJ; Sivasubramanian, S; Subramaniam, S; Tseng, YC1
Li, M; Pan, J; Qiu, J; Shen, Z; Wang, H; Wu, W; Xu, K; Yang, G; Zhang, X; Zhang, Y1
Chen, WL; Li, F; Li, JZ; Liu, C; Liu, Y; Tang, Y; Yang, SD; Yuan, ZQ; Zhang, XN; Zhou, XF1
Chen, DS; Chen, YJ; Chen, YY; Hsieh, HY; Lee, AL; Tsai, LH; Wey, SL; Young, TH1

Other Studies

11 other study(ies) available for urocanic acid and chitosan

ArticleYear
Efficient gene delivery by urocanic acid-modified chitosan.
    Journal of controlled release : official journal of the Controlled Release Society, 2003, Dec-12, Volume: 93, Issue:3

    Topics: Cell Line; Chitin; Chitosan; DNA; Dose-Response Relationship, Drug; Drug Delivery Systems; Genetic Therapy; Humans; Urocanic Acid

2003
Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:4

    Topics: Administration, Inhalation; Aerosols; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Survival; Chitosan; Genes, ras; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Neovascularization, Pathologic; RNA-Binding Proteins; Urocanic Acid

2006
Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) mice.
    Cancer gene therapy, 2008, Volume: 15, Issue:5

    Topics: Administration, Inhalation; Aerosols; Animals; Chitosan; Disease Models, Animal; Gene Deletion; Genes, ras; Genetic Vectors; Lung Neoplasms; Male; Mice; PTEN Phosphohydrolase; Urocanic Acid

2008
Urocanic acid-modified chitosan-mediated p53 gene delivery inducing apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its antitumor effect in vitro and in vivo.
    Biochemical and biophysical research communications, 2008, Dec-12, Volume: 377, Issue:2

    Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Genetic Therapy; Humans; Liver Neoplasms; Transfection; Tumor Suppressor Protein p53; Urocanic Acid

2008
[Synthesis and characterization of urocanic acid-coupled chitosan as gene vector].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2008, Volume: 43, Issue:12

    Topics: Chitosan; Deoxyribonuclease I; DNA; Drug Delivery Systems; Genetic Therapy; Genetic Vectors; Hep G2 Cells; Humans; Particle Size; Plasmids; Transfection; Urocanic Acid

2008
Enhanced antitumor efficacies of multifunctional nanocomplexes through knocking down the barriers for siRNA delivery.
    Biomaterials, 2015, Volume: 44

    Topics: Animals; Antineoplastic Agents; Buffers; Cell Line, Tumor; Chitosan; Citraconic Anhydrides; Endocytosis; Endosomes; Female; Galactose; Gene Silencing; Gene Transfer Techniques; Humans; Liver; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Polyamines; Proton Magnetic Resonance Spectroscopy; RNA, Small Interfering; Static Electricity; Urocanic Acid; Vascular Endothelial Growth Factor A

2015
Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.
    Colloids and surfaces. B, Biointerfaces, 2016, Jul-01, Volume: 143

    Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Line, Tumor; Cell Survival; Chitosan; Fusion Regulatory Protein-1; Inflammation; Inflammation Mediators; Macrophages; Mice; Microscopy, Electron, Transmission; Molecular Structure; Nanoparticles; RNA, Small Interfering; Tumor Necrosis Factor-alpha; Urocanic Acid; X-Ray Diffraction

2016
In vitro and in vivo assessment of chitosan modified urocanic acid as gene carrier.
    Materials science & engineering. C, Materials for biological applications, 2017, Jan-01, Volume: 70, Issue:Pt 1

    Topics: 3T3 Cells; Animals; Animals, Genetically Modified; Cell Death; Cell Survival; Chick Embryo; Chitosan; DNA; Endonucleases; Gene Transfer Techniques; HeLa Cells; Humans; Mice; Nanoparticles; Ninhydrin; Particle Size; Plasmids; Restriction Mapping; Spectroscopy, Fourier Transform Infrared; Static Electricity; Transfection; Urocanic Acid

2017
[Experimental research of neutrophil gelatinase-associated lipocalin siRNA encapsulated by urocanic acid-coupled chitosan on colon cancer cells].
    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2017, Jun-25, Volume: 20, Issue:6

    Topics: Cell Line, Tumor; Chitosan; Colonic Neoplasms; Humans; Lipocalin-2; RNA, Small Interfering; Transfection; Urocanic Acid

2017
Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Liberation; Female; Hydrogen-Ion Concentration; Malonates; Mice, Inbred BALB C; Nanoparticles; Particle Size; Tissue Distribution; Urocanic Acid

2017
Novel Application of Photo-Crosslinked Urocanic-Acid-Modified Chitosan in Corneal Wounds.
    ACS biomaterials science & engineering, 2022, 05-09, Volume: 8, Issue:5

    Topics: Chitosan; Corneal Perforation; Humans; Hydrogels; Photosensitizing Agents; Urocanic Acid

2022